24/7 Wall St. » CLZR

The 52-Week Low Club (MCK)(VSE)(ATRC)(CLZR)

247wallst — Mon, 03 Nov 2008 16:16:03 +0000

McKesson (MCK) Sales slowdown and downgrade. Drops to $35.81 from 52-week high of $68.43.

Verasun Energy (VSE) Chapter 11. Sells down to $.20 from 52-week high of $17.75.

Atricure (ATRC) Department of Justice probe. Roth Capital downgrade. The daily double. Drops to $3 from 52-week high of $14.38.

Candela (CLZR) Looking at strategic alternatives and posted poor earnings.

Douglas A. McIntyre

Posted in HI/LOW Tagged: ATRC, CLZR, MCK, VSE

52-Week Lows (August 27, 2007)

247wallst — Mon, 27 Aug 2007 15:00:35 +0000

Not all of these are low closes but these hit new 52-week lows if not……

Candela (CLZR) keeps hitting the list….

Carmike Cinema’s (CKEC)…if movies hit $4 Billion and they can’t make money then they better jack up thge popcorn prices…..

Chico’s F A S (CHS) put in a new 52-week low intraday, although this sub-$17.00 marks a low if it closes here.

Delta Petroleum (DPTR) may not be a 52-week low close but that was intraday.

Eagle Test Systems Inc. (EGLT) is on that seems to keep hitting the list of late.

Franklin Electric Co., Inc., (FELE)…groundwater and fuel pumping systems… isn’t that supposed to be a hot area???

St. Joe Co. (JOE)…. would you expect anything else from a company that builds small communities and transplant-a-marsh to a town player in this housing and loan environment???

Kellwood (KWD) isn’t selling enough men’s and women’s sportwear?

Neurocham (NRMX)… today’s biotech implosion

Restoration Hardware Inc. (RSTO)… needs to restore itself maybe. Too bad, because it’s a neat shop. If houses aren’t selling and if money gets tight, this one can easily be avoided.

Jon C. Ogg
August 27, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

52-Week Low: Wall Street Tells Candela ‘Seeing Is Believing’ (CLZR, PMTI, ELOS)

247wallst — Thu, 23 Aug 2007 12:07:56 +0000

Candela Corp. (NASDAQ:CLZR) is one of the cosmetic/medical laser companies that has seen better times than recent trading, and it showed up in the 52-week low club in a screen today. The company posted a loss earlier this week on shipment delays and even yesterday said it was expanding its share buyback plan to offset this. The 2.3 million shares in total (including the old buyback plan) would represent close to 10% of the stock outstanding. With under $40 million cash and equivalents on the books and posting a net loss, it appears that most feel they won’t be too active of a share buyer.

Perhaps another thing is still hurting Candela: the IPO filing of Reliant Technologies from last week. At $7.75, Candela (CLZR) shares are down 3% on the day, and down about 1% under the $7.81 prior low for the year before today’s trading session. Shares have traded as high as $14.67 over the last year.

Palomar Medical Tech (NASDAQ:PMTI) is only about 10% off of 52-week lows and still nearly off 50% from its yearly highs. Syneron Medical Ltd. (NASDAQ:ELOS) is only about 8% off of its 52-week lows, although it down less in comparison at about -20% off of its yearly highs.

Jon C. Ogg
August 23, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

IPO Filing: Reliant Technologies, Cosmetic Lasers (PMTI, ELOS, CLZR)

247wallst — Thu, 16 Aug 2007 08:18:59 +0000

Reliant Technologies, Inc. has filed to come public via an IPO with an undetermined ticker and undetermined exchange. For filing purposes, it lists that it will sell up to $95 million in common stock. Piper Jaffray and Banc of America are tapped as lead underwriters with Jefferies and RBC Capital listed as co-managers. This looks like it is that ‘pending IPO in the wings’ that has been hurting other laser operators like Palomar Medical Technologies (NASDAQ:PMTI), Syneron Medical Ltd. (ELOS), and Candela Corp. (CLZR).

The company’s main product is the Fraxel Family, a unique laser and medical device company that designs, develops and markets non-surgical therapies for the treatment of various skin conditions.Fraxel laser systems have created a new class of skin rejuvenation therapy and provide patients with consistent and effective treatments that can be delivered quickly without significant pain or downtime. Its Fraxel laser systems are used by physicians to treat a broad range of skin conditions that include wrinkles and fine lines, acne and surgical scars, pigmentation, sun damage, uneven tone and texture and melasma. Patients undergo treatments in order to reverse the signs of aging, achieve healthier, younger looking skin and improve their overall appearance.

Following the launch of its first Fraxel laser system in 2004, Reliant’s revenues have grown from $4.5 million in 2004 to $57.5 million in 2006, and to $35.3 million for the first six months of 2007. Reliant intends to expand the customer base to include general practitioners, gynecologists, ophthalmologists and others. As of June 30, 2007, it has sold approximately 1,200 Fraxel laser systems worldwide. In addition the Fraxel ‘re:store system’ is targeted to provide treatments for acne and surgical scars, deeper lines and wrinkles and actinic keratoses; and it plans to launch the Fraxel ‘re:pair system’ for more sever conditions in 2008.

Jon C. Ogg
August 16, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.